Cooley
Lindsey O'Crump
- Deals
- 4
- Latest
- May 2026
- Most deals in
- Biotech
Firm
- Cooley Law firm · 2026 · 4 deals
Often works with
- Alessandra Murata 3 deals together
- Josh Himmelstern 2 deals together
- Megan Browdie 2 deals together
- Todd Gluth 2 deals together
- Rama Padmanabhan 2 deals together
- Jenny Ge 2 deals together
- Joanna Zhang 2 deals together
- John DelMastro 2 deals together
Deals
Deals dated after 30 September 2026 are still being collected.
Columns
| May 2026 | Engage Bio | – | Eli Lilly | Acquisition | Legal adviser to Engage Bio (target) | Announced | 202.0 | Biotech+1 | Eli Lilly acquisition of Engage Bio |
| May 2026 | Candid Therapeutics | – | UCB | Acquisition | Legal adviser to Candid Therapeutics (target) | Announced | 2,200.0 | Biotech+1 | UCB acquisition of Candid Therapeutics |
| Mar 2026 | Candid Therapeutics | – | – | Placement | Legal adviser to the issuer | Pending | 505.0 | Biotech+1 | Candid Therapeutics placement |
| Feb 2026 | 35Pharma | – | GSK | Acquisition | Legal adviser to 35Pharma (target) | Announced | 950.0 | Biotech+1 | GSK acquisition of 35Pharma |
Deals where Lindsey O'Crump is named on the firm's deal team, by the firm or the press.